Incidence and risk factors for neovascular age-related macular degeneration in the fellow eye
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Link
http://link.springer.com/article/10.1007/s00417-018-4100-z/fulltext.html
Reference28 articles.
1. Waldstein SM, Simader C, Starurenghi G et al (2016) Morphology and visual acuity in aflibercept and ranibizumab therapy for neovascular age-related macular degeneration in the VIEW trials. Ophthalmology 123(7):1521–1529
2. Brown DM, Michels M, Kaiser PK et al (2009) Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 116(1):57–65
3. Abraham P, Yue H, Wilson L (2010) Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2. Am J Ophthalmol 150(3):315–324
4. Heier JS, Brown DM, Chong V et al (2012) Intravitral aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119(12):2537–2548
5. Ho AC, Busbee BG, Regillo CD et al (2014) Twenty-four month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ophthalmology 121(11):2181–2192
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Incidence and risk factors of fellow-eyes wet conversion in unilateral neovascular age-related macular degeneration over 15-year follow-up;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-08-23
2. Factors associated with loss to follow‐up in patients with advanced age‐related macular degeneration: A telehealth recall initiative;Ophthalmic and Physiological Optics;2024-02-29
3. Early Optical Coherence Tomography Biomarkers for Selected Retinal Diseases—A Review;Diagnostics;2023-07-21
4. Second eyes to develop neovascular age-related macular degeneration have fewer symptoms and better one-year visual outcomes;BMC Ophthalmology;2023-07-07
5. Visual acuity and causes of central visual loss in the adult Danish population 2020–2022. Results from the FORSYN study;Acta Ophthalmologica;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3